Evidence map›Paper›PMID 35321654›Full record

ArticleBMC primary care2022

Implementation of a text messaging intervention to patients on warfarin therapy in Brazilian primary care units: a quasi-experimental study.

Maira Viana Rego Souza-Silva, Mara Luiza de Paiva Domingues, Victor Schulthais Chagas, Daniella Nunes Pereira, Laura Caetano de Sá, Mychelle Stefany Santos Almeida, Thaís Lorenna Souza Sales, Magda César Raposo, Nathalia Sernizon Guimarães, João Antônio de Queiroz Oliveira and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Maira Viana Rego Souza-SilvaThe Post-graduate Program in Health Sciences: Infectious Diseases and Tropical Medicine, Medical School, Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 190, Belo Horizonte, 30130-100, Brazil. mairavsouza@gmail.com.ORCID 0000-0003-2079-7291
Mara Luiza de Paiva DominguesThe Graduate Program in Pharmaceutical Sciences, Universidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, room 301, Divinópolis, 35501-296, Brazil.ORCID 0000-0003-2055-1048
Victor Schulthais ChagasDepartment of Medicine and Nursing - DEM, Universidade Federal de Viçosa, Av. Peter Henry Rolfs, University Campus, Viçosa, 36570-900, Brazil.ORCID 0000-0002-9058-2803
Daniella Nunes PereiraMedical School, Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 190, Belo Horizonte, 30130-100, Brazil.ORCID 0000-0002-3124-9322
Laura Caetano de SáFaculdade Ciências Médicas de Minas Gerais - FCMMG, Alameda Ezequiel Dias, 275, Belo Horizonte, 30130-110, Brazil.ORCID 0000-0002-0845-5814
Mychelle Stefany Santos AlmeidaMedical School, Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 190, Belo Horizonte, 30130-100, Brazil.ORCID 0000-0001-9333-9035
Thaís Lorenna Souza SalesThe Graduate Program in Health Sciences, Universidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, Divinópolis, 35501-296, Brazil.ORCID 0000-0002-1571-3850
Magda César RaposoThe Graduate Program in Pharmaceutical Sciences, Universidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, room 301, Divinópolis, 35501-296, Brazil.ORCID 0000-0003-3082-9015
Nathalia Sernizon GuimarãesThe Post-graduate Program in Health Sciences: Infectious Diseases and Tropical Medicine, Medical School, Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 190, Belo Horizonte, 30130-100, Brazil.ORCID 0000-0002-0487-0500
João Antônio de Queiroz OliveiraUniversity Hospital, Universidade Federal de Minas Gerais, Avenida Professor Alfredo Balena, 110, Belo Horizonte, 30130-110, Brazil.ORCID 0000-0003-3116-4713
Antonio Luiz Pinho RibeiroInstitute for Health Technology Assessment (IATS/ CNPq), Rua Ramiro Barcelos, 2359. Prédio 21 | Sala 507, Porto Alegre, 90035-903, Brazil.ORCID 0000-0002-2740-0042
Clareci Silva CardosoUniversidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, CEP 35501-296, Divinópolis, Brazil.ORCID 0000-0003-0689-1644
Maria Auxiliadora Parreiras MartinsDepartment of Pharmaceutical Sciences, Universidade Federal de Minas Gerais, Avenida Antonio Carlos, 6627, Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.ORCID 0000-0002-5211-411X
Thais Bueno EnesThe Graduate Program in Pharmaceutical Sciences, Universidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, room 301, Divinópolis, 35501-296, Brazil.ORCID 0000-0001-9233-4398
Thiago Barbabela de Castro SoaresUniversidade Federal de Minas Gerais, Av. Professor Alfredo Balena, 110, CEP: 30130-100, Belo Horizonte, Brazil.ORCID 0000-0002-6972-5507
André Oliveira BaldoniUniversidade Federal de São João Del-Rei, R. Sebastião Gonçalves Coelho, 400, Divinópolis, CEP 35501-296, Brazil.ORCID 0000-0001-6379-0415
Milena Soriano MarcolinoInstitute for Health Technology Assessment (IATS/ CNPq), Rua Ramiro Barcelos, 2359. Prédio 21 | Sala 507, Porto Alegre, 90035-903, Brazil.ORCID 0000-0003-4278-3771
Universidade Federal de Minas Gerais · BRFederal University of São João del-Rei · BRFaculdade de Ciências Médicas de Minas Gerais · BRUniversidade Federal de Viçosa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWarfarin remains the most affordable oral anticoagulant in many countries. However, it may have serious side effects, and the success of the therapy depends on the patient's understanding of the medication and their adherence to treatment. The use of short messages services (SMS) is a strategy that can be used to educate patients, but there are no studies evaluating this intervention in patients taking warfarin. Therefore, we aimed to develop, implement, and assess the feasibility of an intervention using SMS to primary care patients taking warfarin in a medium-sized Brazilian city.

methodsA bank of 79 SMS was drafted and validated by an expert panel. During 6 months, three times a week, patients received messages about anticoagulation with warfarin. At baseline and after 3 months, we assessed their knowledge and adherence with validated instruments. At the end of the follow-up, participants answered a satisfaction questionnaire. Subsequently, a scale-up phase was conducted, with another round of the intervention including 82 participants (29 from the first phase and 53 newly recruited). Seven months after the end of the scale-up, we asked the patients for their insights about the long-term effects of this program. All patients signed informed consent. The study was approved by the Research and Ethics committee of the Universidade Federal de Minas Gerais.

resultsIn the pilot, 33 (89.2%) patients completed the follow-up. Among the participants who answered the satisfaction questionnaire (n = 29), 86.2% considered that the intervention motivated a healthy lifestyle and improved their understanding of warfarin therapy. All patients were willing to continue receiving the messages. Adherence measured by the Measure of Adherence to Treatment (MAT) test was high in the pre-intervention assessment and remained high (96.7% vs. 93.3%; p = 1.0000). The proportion of patients who achieved > 75% correct answers on the Oral Anticoagulation Knowledge (OAK) test increased from 6.5% to 25.6, p = 0.0703. In the scale-up, 23 patients answered the long-term assessment questionnaire. The main long-term knowledge reported was dietary information. Nine patients received the messages but did not remember their content.

conclusionThe intervention was well-accepted and had a positive impact on patient's knowledge about oral anticoagulation therapy. The scale-up assessment reinforced the need to constantly monitor digital interventions.

Indexed as

Text MessagingWarfarinAnticoagulantsBrazilHumansPrimary Health CareAnticoagulantsWarfarinAnticoagulantCardiovascular diseaseDigital healthE-healthM-healthSMSText-messagesWarfarin

Identifiers

PMID35321654
PMCPMC8942053
OpenAlexW4226093017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.